Anosmia is the clinical term for the inability to smell. Few people appreciate the range of information provided by the sense of smell. Even fewer think about what would happen if that source of information disappeared. Yet olfaction is a vulnerable sense, and smell disorders and loss are common.
Launched in 2014, the Monell Anosmia Project seeks to better understand the underlying causes of anosmia and develop effective treatments. We also work with patients, physicians, and other researchers to increase awareness about the prevalence and consequences of this invisible disorder.
The Monell Anosmia Project is made possible primarily through contributions from individuals who believe as we do that research is the antidote to the challenges of smell loss. Donations of all sizes are invested immediately in scientists who are fighting for the millions of people worldwide living without smell.
Most recently, Monell has become involved globally in the chemosensory aspects of COVID-19 research, including sudden smell loss as a primary symptom. Please visit our COVID-19 Resources page to learn more about our efforts during this worldwide health crisis and read more about our current anosmia research in general.
We partner with many like-minded organizations to further awareness about smell loss and advocate for more research, including abScent, Fifth Sense, Anosmia Awareness, and the Global Consortium on Chemosensory Research.
Having trouble explaining anosmia? Share this page